
Castle Biosciences, Inc.
CSTLNASDAQHealthcare● Active
$20.29
$-0.72(-3.43%)
Market Cap$615394726
P/E Ratio—
52W High$44.28
52W Low$14.59
Castle Biosciences, Inc.(CSTL)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · CSTL · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.34B | $0.33B | $0.22B | $0.14B | $0.09B |
| Cost of Revenue | $0.07B | $0.06B | $0.04B | $0.03B | $0.02B |
| Gross Profit | $0.27B | $0.27B | $0.17B | $0.11B | $0.08B |
| Gross Margin %(computed) | 79.37% | 81.87% | 79.53% | 76.64% | 83.18% |
| Operating Expenses | |||||
| R&D Expenses | $0.05B | $0.05B | $0.05B | $0.04B | $0.03B |
| G&A Expenses | $0.09B | $0.08B | $0.07B | $0.06B | $0.00B |
| Total Operating Expenses | $0.32B | $0.26B | $0.24B | $0.18B | $0.12B |
| Operating Income | ($0.04B) | $0.01B | ($0.07B) | ($0.07B) | ($0.04B) |
| Operating Margin %(computed) | -12.44% | 2.61% | -30.93% | -53.16% | -42.60% |
| Interest Income | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.03B) | $0.02B | ($0.06B) | ($0.07B) | ($0.04B) |
| Income Tax Expense | ($0.01B) | $0.00B | $0.00B | ($0.00B) | ($0.01B) |
| Net Income | ($0.02B) | $0.02B | ($0.06B) | ($0.07B) | ($0.03B) |
| Net Margin %(computed) | -7.02% | 5.49% | -26.15% | -48.99% | -33.26% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.83 | $0.66 | $-2.14 | $-2.58 | $-1.24 |
| Wtd Avg Shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B |
| EBITDA | $0.01B | $0.04B | ($0.05B) | ($0.06B) | ($0.04B) |
| EBITDA Margin %(computed) | 3.30% | 11.48% | -20.49% | -42.57% | -38.91% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B
深入了解Castle Biosciences, Inc.
关于Castle Biosciences, Inc.(CSTL)损益表
Castle Biosciences, Inc.(CSTL)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,CSTL实现营收$0.34B,毛利润$0.27B(毛利率79.37%),净利润($0.02B)(净利率-7.02%)。
常见问题
CSTL · 4 问Castle Biosciences, Inc.(CSTL)2025财年营收为$0.34B,同比up3.7%。
CSTL revenueCSTL salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08